JREM:XETRA:XETRA-JPMorgan ETFs (Ireland) ICAV - Global Emerging Markets Research Enh Idx Eq (ESG) UCITS ETF USD Acc (EUR)

ETF | Others |

Last Closing

USD 27.34

Change

+0.47 (+1.73)%

Market Cap

USD 1.12B

Volume

7.77K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.64 (-1.24%)

USD 450.46B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.22 (-1.33%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.32 (-1.21%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.34 (-1.21%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.36 (-1.50%)

USD 157.79B
TM5:XETRA T-MOBILE US INC.DL-00001

+2.10 (+1.40%)

USD 126.93B
8R80:XETRA Amundi Index Solutions - Amund..

-1.22 (-0.87%)

USD 104.09B
JARI:XETRA Amundi Index Solutions - Amund..

-0.59 (-1.34%)

USD 101.29B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.65 (-1.27%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+0.42 (+0.08%)

USD 80.38B

ETFs Containing JREM:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.78% 57% F 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.78% 56% F 58% F
Trailing 12 Months  
Capital Gain 11.05% 57% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.05% 56% F 59% D-
Trailing 5 Years  
Capital Gain 13.40% 44% F 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.40% 43% F 45% F
Average Annual (5 Year Horizon)  
Capital Gain 9.06% 73% C 70% C-
Dividend Return 9.06% 72% C 69% C-
Total Return N/A 61% D- 52% F
Risk Return Profile  
Volatility (Standard Deviation) 225.12% 3% F 2% F
Risk Adjusted Return 4.03% 32% F 33% F
Market Capitalization 1.12B 80% B- 72% C

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.